Psychedelic Business News Spotlight: January 22, 2021

Psychedelic Business News Spotlight: January 22, 2021

This week in psychedelic industry news: the first psychedelic stock index, new products, mergers, and funds.

Daniel Carcillo’s Wesana Health Raises $4 Million to Expand Psychedelic Research

,
Wesana Health, founded by former NHL star Daniel Carcillo, has raised $4 million to continue its psychedelic research for traumatic brain injuries.
Psychedelic Business News Spotlight: January 15, 2021

Psychedelic Business News Spotlight: January 15, 2021

This week in psychedelic business news, IPOs, employee stock options, mergers, research, and more.
Psychedelic Business News

Psychedelic Business News Spotlight: January 08, 2021

This week in psychedelic business news, Mydecine, Neon Mind, Ehave, and more.
NeonMind Takes Psilocybin Therapy Public

NeonMind Takes Psilocybin Therapy Public

NeonMind is the latest psychedelic company to go public. It's the first to launch on the Canadian Stock Exchange in 2021.
5 Psychedelic Apps

These 5 Apps Are Made for Taking Psychedelics

,
Taking psychedelics? There's an app for that. These companies are leading the way with trip guides, support, and more.
Psychedelic Trend Predictions 2021

7 Psychedelic Trend Predictions for 2021

The momentum for psychedelics is snowballing, and 2021 is expected to be an even bigger and better year for the industry.
UK psychedelic VC fund

Psychedelic Business News Spotlight: December 17, 2020

The UK gets its first psychedelic VC fund, psychedelic treatment for Parkinson's, and more business news.

Psychedelic Business News Spotlight: December 10, 2020

This week in psychedelic business news: Motley Fool bets on MindMed, mushrooms go from Jamaica to Canada, and more.
Spravato

Psychedelic Life Science Company Cybin Acquires Ketamine Drug Maker Adelia Therapeutics

Cybin Inc., has acquired the ketamine drug Spravato manufacturer Adelia Therapeutics in its first major acquisition.